Seminars in Oncology

Papers
(The H4-Index of Seminars in Oncology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Clinical efficacy and security analysis of DEB-TACE combined with trans arterial infusion of carrelizumab in the therapy of advanced liver cancer56
Breaking barriers: Deciphering the mechanisms of Olaparib resistance in prostate cancer53
Hepatitis B Virus Reactivation in Cancer Patients Receiving Chemotherapy—A Systematic Review and Meta-Analysis31
Airway disorders associated with immune checkpoint inhibitor therapy: Two case reports and a systematic review30
Integrated analysis of scRNA-seq and bulk RNA-seq data identifies BHLHE40 as a key gene in pancreatic cancer progression and gemcitabine resistance24
Overexpression of CAD in stomach adenocarcinoma tissues and its clinical significance20
Unlocking the therapeutic potential of polyphenols: Promising advances and future directions in pancreatic cancer treatment20
Deciphering the US Regulatory Framework: Comparison Between Oncology Biosimilars and Reference Biologics18
Table of Contents18
Pretreatment eosinophilia as a biomarker for adverse outcomes in non-small cell lung cancer patients receiving immune checkpoint inhibitors: A systematic review and meta-analysis18
Explainable machine learning and feature interpretation to predict survival outcomes in the treatment of lung cancer18
Psoas muscle depletion correlates with poor prognosis and compromised immunity in resectable gastric cancer: A multicenter study17
Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations17
Editorial Board16
0.58978199958801